Codex DNA, Inc. (DNAY) Income Annual - Discounting Cash Flows
DNAY
Codex DNA, Inc.
DNAY (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
Report Filing 2024-11-07 2023-03-22 2022-03-23 2020-12-31
Revenue 3.12 27.43 11.04 6.58
Cost of Revenue 2.91 11.84 6.74 2.95
Gross Profit 0.21 15.6 4.3 3.62
Operating Expenses 17.18 65.31 44.61 19.99
Research & Development 4.64 23.46 14.55 8.93
Selling, General and Administrative 11.18 38.62 25.12 11.06
Other Operating Expenses 1.35 3.23 4.94 0
Operating Income -16.97 -49.71 -40.31 -16.36
Net Non-Operating Interest 0.671 1.22 1.37 -0.69
Interest Income 0.238 0 0 0
Interest Expense -0.433 -1.22 -1.37 0.69
Equity & Other Income/(Expense) -1.44 0.048 0 -0.954
Income Before Tax -17.74 -48.45 -38.94 -18
Income Tax Expense -0.002 -0.024 0.014 0.005
Income Attributable to Non-Controlling Interest 2.7 0 0 0
Net Income -20.44 -48.42 -38.96 -18.01
Depreciation and Amortization 0 3.23 0.908 1.46
EBITDA -16.97 -46.48 -39.41 -14.9
Earnings Per Share (EPS) -1.17 -1.64 -1.83 -0.84
Diluted Earnings Per Share -1.17 -1.64 -1.83 -0.84
Weighted Average Shares Outstanding 17.73 29.46 21.32 21.32
Diluted Weighted Average Shares Outstanding 17.73 29.46 21.32 21.32
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program